Scott Blumberg is the founder of Ceribell. Ceribell has raised $188M in total funding. Latest round: Series C. Backed by Horizon, Optima Capital, LivaNova.
Scott Blumberg is the Chief Financial Officer at Ceribell, a medical technology company focused on developing a point-of-care EEG platform for detecting seizures in acute-care settings. Ceribell aims to improve the diagnosis and treatment of patients at risk of seizures.
Full founder directory · Investor directory · Company funding database · Fundraising library